The association of the metabolic syndrome with PAI-1 and t-PA levels

Cardiology Research and Practice

Volumn 1, Issue 1, 2011, Pages

  Coffey, Christopher S ^a   Asselbergs, Folkert W ^b   Hebert, Patricia R ^c   Hillege, Hans L ^d   Li, Qing ^e   Moore, Jason H ^f   Van Gilst, Wiek H ^d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e Department of ConvaTec Inc   (United States)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ALBUMINURIA; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; SMOKING;

EID: 79959443635     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2011/541467     Document Type: Article

References (38)

1. Gami A. S., Witt B. J., Howard D. E., Erwin P. J., Gami L. A., Somers V. K., Montori V. M., Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies Journal of the American College of Cardiology 2007 49 4 403 414 (Pubitemid 46135879)
2. Laaksonen D. E., Lakka H. M., Niskanen L. K., Kaplan G. A., Salonen J. T., Lakka T. A., Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study American Journal of Epidemiology 2002 156 11 1070 1077 (Pubitemid 35396938)
3. Anand S. S., Yi Q., Gerstein H., Lonn E., Jacobs R., Vuksan V., Teo K., Davis B., Montague P., Yusuf S., Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease Circulation 2003 108 4 420 425 (Pubitemid 36935534)
4. Ridker P. M., Vaughan D. E., Stampfer M. J., Manson J. E., Hennekens C. H., Endogenous tissue-type plasminogen activator and risk of myocardial infarction The Lancet 1993 341 8854 1165 1168 (Pubitemid 23137110)
5. Folsom A. R., Aleksic N., Park E., Salomaa V., Juneja H., Wu K. K., Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study Arteriosclerosis, Thrombosis, and Vascular Biology 2001 21 4 611 617 (Pubitemid 32323396)
6. Mertens I., Verrijken A., Michiels J. J., van der Planken M., Ruige J. B., van Gaal L. F., Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome International Journal of Obesity 2006 30 8 1308 1314 (Pubitemid 44141622)
7. Ridker P. M., Cushman M., Stampfer M. J., Tracy R. P., Hennekens C. H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men The New England Journal of Medicine 1997 336 14 973 979 (Pubitemid 27152782)
8. Ridker P. M., Hennekens C. H., Buring J. E., Rifai N., C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women The New England Journal of Medicine 2000 342 12 836 843 (Pubitemid 30165206)
9. Ford E. S., Giles W. H., Dietz W. H., Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey Journal of the American Medical Association 2002 287 3 356 359 (Pubitemid 34251969)
10. Yudkin J. S., Stehouwer C. D. A., Emeis J. J., Coppack S. W., C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 972 978 (Pubitemid 29177345)
11. Mogensen C. E., Keane W. F., Bennett P. H., Jerums G., Parving H. H., Passa P., Steffes M. W., Striker G. E., Viberti G. C., Prevention of diabetic renal disease with special reference to microalbuminuria The Lancet 1995 346 8982 1080 1084
12. Hillege H. L., Fidler V., Diercks G. F. H., van Gilst W. H., de Zeeuw D., van Veldhuisen D. J., Gans R. O. B., Janssen W. M. T., Grobbee D. E., de Jong P. E., Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 2002 106 14 1777 1782
13. Borch-Johnsen K., Feldt-Rasmussen B., Strandgaard S., Schroll M., Jensen J. S., Urinary albumin excretion: an independent predictor of ischemic heart disease Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 8 1992 1997 (Pubitemid 29379934)
14. Mykknen L., Zaccaro D. J., O'Leary D. H., Howard G., Robbins D. C., Haffner S. M., Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects: the Insulin Resistance Atherosclerosis Study (IRAS) Stroke 1997 28 9 1710 1716 (Pubitemid 27391437)
15. Palaniappan L., Carnethon M., Fortmann S. P., Association between microalbuminuria and the metabolic syndrome: NHANES III American Journal of Hypertension 2003 16 11 952 958 (Pubitemid 37315495)
16. Hirano T., Kashiwazaki K., Moritomo Y., Nagano S., Adachi M., Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients Diabetes Research and Clinical Practice 1997 36 1 11 18 (Pubitemid 27244818)
17. Agewall S., Lindstedt G., Fagerberg B., Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men Atherosclerosis 2001 157 1 197 202 (Pubitemid 32539371)
18. Meigs J. B., Mittleman M. A., Nathan D. M., Tofler G. H., Singer D. E., Murphy-Sheehy P. M., Lipinska I., D'Agostino R. B., Wilson P. W. F., Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study Journal of the American Medical Association 2000 283 2 221 228 (Pubitemid 30039222)
19. Asselbergs F. W., Williams S. M., Hebert P. R., Coffey C. S., Hillege H. L., Navis G., Vaughan D. E., van Gilst W. H., Moore J. H., The gender-specific role of polymorphisms from the fibrinolytic, renin-angiotensin, and bradykinin system in determining plasma t-PA and PAI-I levels Thrombosis and Haemostasis 2006 96 4 471 477 (Pubitemid 44560681)
20. Grundy S. M., Brewer H. B. Jr., Cleeman J. I., Smith S. C. Jr., Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition Circulation 2004 109 3 433 438 (Pubitemid 38133916)
21. Harrell F. E., Regression Modeling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis 2001 chapter 5 New York, NY, USA Springer
22. Muller K. E., Fetterman B. A., Regression and ANOVA: an Integrated Approach Using SAS Software 2002 chapter 11 Cary, NC, USA SAS Institute
23. Hu G., Qiao Q., Tuomilehto J., Balkau B., Borch-Johnsen K., Pyorala K., Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women Archives of Internal Medicine 2004 164 10 1066 1076 (Pubitemid 38668985)
24. Alessi M. C., Juhan-Vague I., PAI-1 and the metabolic syndrome: links, causes, and consequences Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 10 2200 2207 (Pubitemid 44465712)
25. Brown N. J., Agirbasli M. A., Williams G. H., Litchfield W. R., Vaughan D. E., Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1 Hypertension 1998 32 6 965 971 (Pubitemid 29001421)
26. Skurk T., Lee Y. M., Hauner H., Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture Hypertension 2001 37 5 1336 1340 (Pubitemid 34163591)
27. Gorzelniak K., Engeli S., Janke J., Luft F. C., Sharma A. M., Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension Journal of Hypertension 2002 20 5 965 973 (Pubitemid 34913678)
28. Asselbergs F. W., Williams S. M., Hebert P. R., Epistatic effects of polymorphisms in genes from the rennin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels Genomics 2007 89 362 369 (Pubitemid 46205121)
29. Asselbergs F. W., Williams S. M., Hebert P. R., The effects of polymorphisms in genes from the rennin-angiotensin, bradykinin, and fibrinolytic systems on plasma t-PA and PAI-1 levels are dependent on environmental context Human Genetics 2007 122 275 281 (Pubitemid 47616535)
30. Tofler G. H., Massaro J., Levy D., Mittleman M., Sutherland P., Lipinska I., Muller J. E., D'Agostino R. B., Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study) American Journal of Cardiology 2005 96 9 1280 1283 (Pubitemid 41505409)
31. Yarnell J. W. G., Sweetnam P. M., Rumley A., Lowe G. D. O., Lifestyle and hemostatic risk factors for ischemic heart disease: the Caerphilly Study Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 1 271 279 (Pubitemid 30048375)
32. Scarabin P.-Y., Aillaud M.-F., Amouyel P., Evans A., Luc G., Ferrires J., Arveiler D., Juhan-Vague I., Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction. The PRIME Study. Prospective Epidemiological Study of Myocardial Infarction Thrombosis and Haemostasis 1998 80 5 749 756 (Pubitemid 28521717)
33. Schneider D. J., Sobel B. E., Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states Proceedings of the National Academy of Sciences of the United States of America 1991 88 22 9959 9963 (Pubitemid 21915754)
34. Asselbergs F. W., Williams S. M., Hebert P. R., Coffey C. S., Hillege H. L., Navis G., Vaughan D. E., van Gilst W. H., Moore J. H., Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits Journal of Thrombosis and Haemostasis 2007 5 2 313 320 (Pubitemid 46139456)
35. Schoenhard J. A., Asselbergs F. W., Poku K. A., Stocki S. A., Gordon S., Vaughan D. E., Brown N. J., Moore J. H., Williams S. M., Male-female differences in the genetic regulation of t-PA and PAI-1 levels in a Ghanaian population Human Genetics 2008 124 5 479 488
36. Sakkinen P. A., Wahl P., Cushman M., Lewis M. R., Tracy R. P., Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome American Journal of Epidemiology 2000 152 10 897 907
37. Rosito G. A., D'Agostino R. B., Massaro J., Lipinska I., Mittleman M. A., Sutherland P., Wilson P. W. F., Levy D., Muller J. E., Tofler G. H., Association between obesity and a prothrombotic state: the Framingham Offspring Study Thrombosis and Haemostasis 2004 91 4 683 689 (Pubitemid 38477447)
38. Festa A., D'Agostino R., Tracy R. P., Haffner S. M., Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study Diabetes 2002 51 4 1131 1137 (Pubitemid 34438360)